¡®ROJ ³í¹®»ó¡¯Àº Àü³âµµ ´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö¿¡ °ÔÀçµÈ ³í¹® Áß¿¡ °¡Àå ¿ì¼öÇÑ ³í¹®À» ¼±Á¤ÇØ ¼ö¿©ÇÏ´Â »óÀÌ´Ù.
³²Åñ١¤Á¤Àç¿í¡¤Á¶ÀÍÁØ ±³¼öÆÀÀº ¡®Á¤À§ üºÎ ¹æ»ç¼± Ä¡·á¸¦ ¹Þ´Â ±¹¼Ò °£¼¼Æ÷¾ÏÁ¾ ȯÀÚÀÇ ¿¹ÈÄ ÀÎÀڷμÀÇ PIVKA-II(PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy)¡¯¶ó´Â ³í¹®À¸·Î ¼ö»óÀÇ ¿µ¿¹¸¦ ¾È¾Ò´Ù.
/äÈñÁ¾ ±âÀÚ chae@kwangju.co.kr